Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 4:13:853-861.
doi: 10.2147/CIA.S146871. eCollection 2018.

Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly

Affiliations

Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly

Chen Shi et al. Clin Interv Aging. .

Abstract

Objective: We studied the efficacy of zoledronic acid (ZOL) infusion on radiographic and clinical outcomes after percutaneous kyphoplasty (PKP) for elderly patients with osteoporotic thoracolumbar fractures (osteoporotic vertebral compression fractures [OVCFs]).

Materials and methods: We retrospectively analyzed 95 elderly patients (age >65 years) with OVCF. All patients were followed up for 2 years. Thirty-two patients were treated with only once-yearly 5 mg ZOL infusion (ZOL group), 34 patients with only PKP (PKP group) and 29 patients received ZOL infusion 3 days after PKP (PKP+ZOL group).

Results: There were no significant differences in the patients' age, gender, body mass index, lumbar spine bone mineral density T-scores, baseline of Visual Analog Scale scores and Oswestry Disability Index scores (P>0.05). The postoperative vertebral heights of patients with OVCF after PKP and PKP+ZOL were 23.70±3.03 and 24.30±3.13 mm, respectively, which were significantly higher than that of patients in ZOL group (P<0.05). The reduction in degrees of kyphotic deformity in the PKP and PKP+ZOL groups were corrected to 8.4° and 8.7°. The bone mineral density T-scores of patients with OVCF in the ZOL group and PKP+ZOL group were significantly higher than that in the PKP group (P<0.05). The Visual Analog Scale and the Oswestry Disability Index scores of the PKP+ZOL and PKP groups were significantly lower than those of the ZOL group (P<0.05). The incidence of recompression vertebral fracture (RVF) in the PKP group was 14.7%, but there was no patient with RVF in the PKP+ZOL group (P<0.05).

Conclusion: Once-yearly 5 mg ZOL infusion combined with PKP could provide beneficial effects in elderly osteoporotic patients with OVCF.

Keywords: clinical outcomes; elderly; osteoporosis; osteoporotic thoracolumbar fractures; percutaneous kyphoplasty; zoledronic acid.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Vertebral body height before and after PKP and/or ZOL infusion. Notes: Data are presented as mean±SD. *P<0.05 PKP group vs ZOL group; **P<0.05 PKP+ZOL group vs ZOL group; #P<0.05 PKP+ZOL group vs PKP group. Pre: before PKP and/or ZOL infusion; post: after PKP and/or ZOL infusion. Abbreviations: PKP, percutaneous kyphoplasty; ZOL, zoledronic acid.
Figure 2
Figure 2
Kyphotic wedge angle before and after PKP and/or ZOL infusion. Notes: Data are presented as mean±SD. *P<0.05 PKP group vs ZOL group; **P<0.05 PKP+ZOL group vs ZOL group; #P<0.05 PKP+ZOL group vs PKP group. Pre: before PKP and/or ZOL infusion; post: after PKP and/or ZOL infusion. Abbreviations: PKP, percutaneous kyphoplasty; ZOL, zoledronic acid.
Figure 3
Figure 3
A 71-year-old female patient with T11 OVCF who received the combination treatment of PKP and ZOL infusion. Notes: (AC) The posteroanterior radiograph of thoracolumbar spine preoperatively, 1 year postoperatively and 2 years postoperatively. (DF) The lateral radiograph thoracolumbar spine preoperatively, 1 year postoperatively and 2 years postoperatively. Abbreviations: OVCF, osteoporotic vertebral compression fracture; PKP, percutaneous kyphoplasty; ZOL, zoledronic acid.
Figure 4
Figure 4
BMD T-scores at lumbar spine before and after PKP and/or ZOL infusion. Notes: Data are presented as mean±SD. *P<0.05 ZOL group vs PKP group; **P<0.05 PKP+ZOL group vs PKP group; #P<0.05 compared with the baseline. Post: after PKP and/or ZOL infusion. Abbreviations: BMD, bone mineral density; PKP, percutaneous kyphoplasty; ZOL, zoledronic acid.
Figure 5
Figure 5
VAS before and after PKP and/or ZOL infusion. Notes: Data are presented as mean±SD. *P<0.05 PKP group vs ZOL group; **P<0.05 PKP+ZOL group vs ZOL group; #P<0.05 compared with the baseline. Pre: before PKP and/or ZOL infusion; post: after PKP and/or ZOL infusion. Abbreviations: PKP, percutaneous kyphoplasty; VAS, Visual Analog Scale; ZOL, zoledronic acid.
Figure 6
Figure 6
ODI before and after PKP and/or ZOL infusion. Notes: Data are presented as mean±SD. *P<0.05 PKP+ZOL group vs ZOL group; **P<0.05 PKP group vs ZOL group; #P<0.05 PKP+ZOL group vs PKP group. Pre: before PKP and/or ZOL infusion; post: after PKP and/or ZOL infusion. Abbreviations: ODI, Oswestry Disability Index; PKP, percutaneous kyphoplasty; ZOL, zoledronic acid.

Similar articles

Cited by

References

    1. Curtis EM, Moon RJ, Dennison EM, Harvey NC, Cooper C. Recent advances in the pathogenesis and treatment of osteoporosis. Clin Med. 2016;16(4):360–364. - PMC - PubMed
    1. Lin X, Xiong D, Peng YQ, et al. Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives. Clin Interv Aging. 2015;10:1017–1033. - PMC - PubMed
    1. Ballane G, Cauley JA, Luckey MM, El-Hajj Fuleihan G. Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int. 2017;28(5):1531–1542. - PubMed
    1. Kung AW. Epidemiology and diagnostic approaches to vertebral fractures in Asia. J Bone Miner Metab. 2004;22(3):170–175. - PubMed
    1. Cauley JA, Chalhoub D, Kassem AM, Fuleihan Gel-H. Geographic and ethnic disparities in osteoporotic fractures. Nat Rev Endocrinol. 2014;10(6):338–351. - PubMed

MeSH terms